Sialidase as a target for inhibitors of influenza virus replication

Bibliography

• HAY AJ: The action of adamantanamines against influ-enza A viruses: inhibition of the M2 ion channel pro-tein. Semin. Virol. (1992) 3:21–30.
   Google Scholar
• AIR GM, LAVER WG: The neuraminidase of influenza virus. Proteins: Struct Fund. Genet. (1989) 6:341–356.
   PubMed Web of Science ®Google Scholar
• VON ITZSTEIN M, WU W-Y, KOK GB et al: Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature (1993) 363:418–423.
   PubMed Web of Science ®Google Scholar
• WOODS JM, BETHELL RC, COATES JAV et al.: 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor of both the sialidase (neu-raminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. (1993) 37:1473–1479.
   PubMed Web of Science ®Google Scholar
• HAYDEN FG, ROLLINS BS, MADREN LK: Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and human respi-ratory epithelium. Antiviral Res. (1994) 25:123–134.
   PubMed Web of Science ®Google Scholar
• HART GJ, BETHELL RC: 2,3-Didehydro-2,4-dideoxy-4-guanidino-N-acetylneuraminic acid (4-guanidino-Neu5Ac2en) is a slow binding inhibitor of sialidase from both influenza A virus and influenza B virus. Biochem. Mol. Biol. Int. (1995) 36:695–703.
   PubMedGoogle Scholar
• FROMTLING RA, CASTARER J: Zanamivir. Drugs Future (1996) 21:375–382.
   Google Scholar
• HAYDEN FG, TREANOR JJ, BETTS RF et al: Safety and efficacy of the neuraminidase inhibitor GG167 in ex-perimental human influenza. J Am. Med. Assoc. (1996) 275:295–299.
   PubMed Web of Science ®Google Scholar
• HAYDEN FG, LOBO M, HUSSEY EK, EASON CU: Efficacy of intranasal GG167 in experimental influenza A and B virus infection. In: Options for the Control of Influenza. Brown LE, Hampson AW, Webster RG (Eds.), Elsevier Science BV, Amsterdam (1990:718–725.
   Google Scholar
• HAYDEN F, OSTERHAUS A, TREANOR J et al.: Efficacy of the neuraminidase inhibitor GG167 in the treatment of influenza virus infections. Antiviral Res. (1997) 34:A74.
   Google Scholar
• MATSUMOTO K, NEROME K, NUMASAKI Y et al: Inhaled and intranasal GG167 in the treatment of influenza A and B: preliminary results. In: Options for the Control of Influenza. Brown LE, Hampson AW, Webster RG (Eds.), Elsevier Science By, Amsterdam (1996) :713–717.
   Google Scholar
• MCKIMM-BRESCHKIN JL, BUCK TJ, SAHASRABUDHE A et al.: Generation and characterisation of variants of NWS/G70C influenza virus after in vitro passage in the presence of 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. Antimicrob. Agents Chemother. (1996) 40:40–46.
   PubMed Web of Science ®Google Scholar
• SAHASRABUDHE A, BLICK T, MCKIMM-BRESCHKIN J: In-fluenza virus variants resistant to GG167 with muta-tions in haemagglutinin. In: Options for the Control of Influenza. Brown LE, Hampson AW and Webster RG (Eds.), Elsevier Science BV, Amsterdam (1990:748–752.
   Google Scholar
• PENN CR, BARNETT JM, BETHELL RC et al.: Selection of influenza virus with reduced sensitvity in vitro to the neuraminidase inhibitor GG167 (4-guanidino-Neu5Ac2en): changes in haemagglutin may compen-sate for loss of neuraminidase activity. In: Options for the Control of Influenza. Brown LE, Hampson AW, Webster RG (Eds.), Elsevier Science BV, Amsterdam (1996)735–740.
   Google Scholar
• ITO T, SUZUKI Y, TAKADA A et al.: Differences in sialicacid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol. (1997) 71:3357–3362.
   PubMed Web of Science ®Google Scholar
• BAUM LG, PAULSON JC: Sialyloligosaccharides of the respiratory epithelium in the selection of human influ-enza virus receptor specificity. Acta Histochem. (1990) 40\(Suppl. 89) :35–38.
   Google Scholar
• KICK TJ, TIONG T, SAHASRABUDHE A et al.: Generation and characterisation of an influenza virus neuramini-dase variant with decreased sensitivity to the neu-raminidase-specific inhibitor 4-guanidino-Neu5Ac2en. Virology (1995) 214:475–484.
   Google Scholar
• STASCHKE KA, COLACINO JM, BAXTER AJ et al.: Molecular basis for the resistance of the influenza viruses to 4-guanidino-Neu5Ac2en. Virology (1995) 214:642–646.
   Google Scholar
• MCKIMM-BRESCHKIN JL, MCDONALD M, BUCK TJ, COL-MAN PM: Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuramin-diase inhibitor 4-guanidino-Neu5Ac2en leads to insta-bility of the enzyme. Virology (1996) 225:240–242.
   PubMed Web of Science ®Google Scholar
• COLACINO JM, GARMAN E, CHIRGADZE NY eta': A single sequence change destabilises the influenza virus neu-raminidase tetramer. Antiviral Res. (1997) 34:A73.
   Google Scholar
• GUBAREVA LV, BETHELL R, HART GJ et al.: Charac-terisation of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. Virol (1996) 70: 1818-1827.
   Google Scholar
• GUBAREVA LV, ROBINSON MJ, BETHELL R, VVEBSTER RG: Catalytic and framework mutations in the neuramini-dase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. J Virol (1997) 71:3385–3390.
   PubMed Web of Science ®Google Scholar
• BAMFORD MJ, CHANDLER M, CONROY R et al.: Synthesis of the potent influenza neuraminidase inhibitor 4-guanidino-Neu5Ac2en. X-ray molecular structure of 5-acetamido - 4 - amino - 2,6 - anhydro-3,4,5 - trideoxy-u-erythro-L-gluco-nononic acid. J. Chem. Soc. Perkin Trans. I (1995) :1173–1180
   Google Scholar
• VON ITZSTEIN M, WU W-Y, JIN B: The synthesis of 2,3-didehydro-2,4- dideoxy - 4-guanidinyl-N-acetyl-neu-raminic acid: a potent influenza virus sialidase inhibi-tor. Carbohydrate Res. (1994) 259:301–305.
   PubMed Web of Science ®Google Scholar
• STARKEY ID, MAHMOUDIAN M, NOBLE D et al: Synthesis and influenza virus sialidase inhibitory activity of the 5-desacetamido analog of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid (GG167). Tetrahe-dron Lett. (1995) 36:299–302.
   Web of Science ®Google Scholar
• SMITH PW, STARKEY ID, HOWES PD et al.: Synthesis and influenza virus sialidase inhibitory activity of analogs of 4-guanidino-Neu5Ac2en (GG167) with modified 5-substituents. Ear. J. Med. Chem. (1996) 31:143–150.
   Google Scholar
• BAMFORD MJ, CASTRO-PICHEL J, PATEL B et al.: Synthesis of 6-, 7- and 8-carbon sugar analogs of potent anti-in-fluenza 2,3-didehydro-2,3-dideoxy-N-acetylneuraminic acid derivatives. J. Chem. Soc. Perkin Trans. I (1995) 1181–1187.
   Google Scholar
• CHANDLER M, CONROY R, COOPER AWJ et al: Ap-proaches to carbocyclic analogs of the potent neu-raminidase inhibitor 4-guanidino-Neu5Ac2en. X-ray molecular structure of N-[(1S,2S,612)-2-azido-6-benzy-loxymethy1-4-formylcyclohex-3-enyl]acetamide.J.Chem. Soc. Perkin Trans I (1995) :1189–1197.
   Google Scholar
• SOLLIS SL, SMITH PW, HOWES PD et al: Novel inhibitors of influenza sialidase related to GG167: synthesis of 4-amino and 4-guanidino-411-pyran-2-carboxylic acid-6-propyl amides; selective inhibitors of influenza A siali-dase. Bioorg. Med. Chem. Lett. (1996) 6:1805–1808.
   Web of Science ®Google Scholar
• SMITH PW, SOLLIS SL, HOWES PD et al: Novel inhibitors of influenza sialidase related to GG167: structure-activ-ity, crystallographic and molecular dynamics studies with 411-pyran-2-carboxylic acid 6-carboxamides. Bioorg. Med. Chem. Lett. (1996) 6:2931–2936.
   Web of Science ®Google Scholar
• KIM CU, LEW W, WILLIAMS MA et al: Influenza neu-raminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design synthesis and structural analysis of carbocyclic sialic acid ana-logues with potent anti-influenza activity. J. Am. Chem. Soc. (1997) 119:681–690.
   PubMed Web of Science ®Google Scholar
• WILLIAMS MA, LEW W, MENDEL DB et al: Structure-activ-ity relationships of carbocyclic influenza neuramini-dase inhibitors. Bioorg. Med. Chem. Lett. (1997) 7:1837–1842.
   Web of Science ®Google Scholar
• LEW W, WILLIAMS MA, MENDEL DB et al.: C3-Thia and C3-carba isosteres of a carbocylic neuraminidase inhibi-tor, (3R, 4R, 55)-4-acetamido-5-amino-3-propoxy-1-cy-clohexene-1-carboxylic acid. Bioorg. Med. Chem. Lett. (1997) 7:1843–1846.
   Web of Science ®Google Scholar
• ZHANG L, WILLIAMS MA, MENDEL DB eta': Synthesis and activity of C2-substituted analogs of influenza neu-raminidase inhibitor GS4071. Bioorg. Med. Chem. Lett. (1997) 7:1847–1850.
   Web of Science ®Google Scholar
• LI W-X, ESCARPE PA, CHEN MS et al: GS4104 is a highly bioavailable prodrug of the novel, potent influenza neuraminidase inhibitor GS4071. Antiviral Res. (1997) 34:A74.
   Google Scholar
• SINGH S, JEDRZEDAS MJ, AIR GM et al.: Structure-basedinhibitors of influenza virus sialidase: a benzoic acid lead with novel interaction.' Med. Chem. (1995) 38:3217–3225.
   Web of Science ®Google Scholar
• SUDBECK EA, JEDRZEDAS MJ, SINGH S et al.: Guanid-nobenzoic acid inhibitors of influenza virus neuramini-dase. j Mot. Biol. (1997) 267:584–594.
   PubMed Web of Science ®Google Scholar